@gayfrose @UHC@UHC this is the second example in a week that I have seen of patients with a United plan trying to obtain authorization for their medications and being denied which is terrible. Please reply and help @gayfrose obtain the necessary approval!!
This June, join us for a virtual Annual Scientific Meeting #AHSAM! The Society is committed to providing attendees with scientific updates to improve care in a safe and accessible format. Access the preliminary program and register here: https://t.co/1RAQIhBwZ1
More great research from #HCNE2020Stowe as Dr. Alise Pham delves into outcomes and tolerability in patients who have switched between CGRP mAb therapies. This is applicable info for real world clinical practice! @PhamAlise@HeadacheCoopNE@GrahamHeadache
Fascinating #photophobia research presented by Dr. Eric Kaiser looking at the involvement of melanopsin and cone cells in the physiology of photophobia in control subjects versus migraine subjects with and without aura. #HCNE2020Stowe@HeadacheCoopNE@GrahamHeadache
Dr. Begasse de Dhaem @obegassededhaem presents data from her scoping review of workplace related disability due to #migraine at #HCNE2020Stowe. More research is needed to understand the full impact of migraine in the work place.
Happy Leap Day! Spending the day at #HCNE2020Stowe. Dr. Alyssa Lebel is speaking about pain matrixes involved in chronic pain, possibly including new daily persistent #headache, and what brain areas might have increased connectivity in this condition. @HeadacheCoopNE
Great talk by Dr. Will Renthal about migraine genetics, which he explains is important to study in order to understand migraine parhophysiology, understand new targets, and hopefully will allow for personalized therapy for this condition! @willrenthal#HCNE2020Stowe
Dr. Licia Grazzi describes possible ways behavioral therapy (by itself or in conjunction w/ medication) works - it can help with stress reduction, decrease autonomic arousal, or even possibly lower baseline excitability of the brain. #AHSAZ@ahsheadache
Epidemiology facts: Migraine is the 2nd most disabling disease in the world and the first most disabling disease in people who are 15-49 years of age. @DawnBuse@ahsheadache#AHSAZ
@AnnikaEhrlich1 is currently talking about risk factors and clinical course of migraine in the Bridge NP/PA pre-course at #AHSAZ. Headache diary use as well as quality of life scores are important for assessing burden of migraine in our patients! @ahsheadache
Calling all APP (NP/PA) attendees at #ASHAM. The APP special interest group will meet at 10 am in the Pennsylvania Convention Center Room 203 A. See you there! @ahsheadache